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(NSTEMI) vs. ST elevation MI (STEMI) MACE was similar for HRPR and
responders [4/113 (3.5%) vs. 6/163 (3.7%), respectively, pNS, for UA/NSTEMI and
1/35 (2.8%) vs. 2/60 (3.3%), respectively, pNS, for STEMI]. The 30 day incidence of
stent thrombosis was only 1 in the HRPR group and was related to medication
noncompliance.
Conclusions: Adjusting anti-platelet therapy for ACS patients on the basis of Veri-
fyNow testing results in low and equivalent MACE at 30 days after PCI, for initial
anti-platelet responders and HRPR patients switched to more effective therapy.
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Background: In recent years, several modifications in rotational atherectomy technique
have been developed. However, no study has evaluated the clinical outcomes of rotational
atherectomy prior to- and during the DES era.
Methods: All patients who underwent rotational atherectomy for complex coronary
lesions in our center prior to- and during the current DES era were retrospectively
enrolled. Baseline clinical and angiographic characteristics were compared; as were
procedural success and clinical outcomes at 1 year.
Results: Among the 215 patients included in the analysis, 74 (22%) were from the
pre-DES era while 141 (78%) were from the DES era. More patients in the DES era
group had history of peripheral vascular disease and hypertension (25% vs. 15.4%,
p0.04) and (96% vs. 77.5%, p0.001), retrospectively. Procedural success was higher in
DES era group (99.6% vs. 93.6%, 0.001); furthermore the DES era group was
associated with a lower in-hospital coronary artery bypass surgery (0.5% vs. 4%, p0.03),
dissection rate (0.0% vs. 2.3%, p0.04), abrupt closure (0.0% vs. 3.8%, p0.006).
One-year follow up showed a lower rate of death in the DES era group (5.0% vs. 14.6%,
p0.04).
Conclusion: In the DES era, rotational atherectomy has become safer and effective
procedure for complex coronary lesions.
Variable DES Era(n141) Pre-DES Era(n74) p Value
6 months follow-up
TVR MACE 14 (9.5%) 7 (11.1%) 0.72
TLR MACE 13 (8.8%) 7 (11.1%) 0.60
Death 6 (4.1%) 6 (9.5%) 0.19
TLR 7 (4.9%) 1 (1.6%) 0.44
TVR 8 (5.6%) 1 (1.6%) 0.28
QWMI 0 0 0.00
NQWMI 3 (2.2%) 0 0.57
ST 0 0 0.00
1 year follow-up
TVR MACE 21 (15%) 12 (25%) 0.11
TLR MACE 20 (14%) 12 (25%) 0.08
Death 7 (5%) 7 (14.5%) 0.04
TLR 13 (9.6%) 5 (11%) 0.77
TVR 14 (10.4%) 5 (11%) 1.00
QWMI 0 0 0.00
NQWMI 3 (2.2%) 0 0.57
ST 0 0 0.00
TVR target vessel revascularization; MACE major adverse cardiovascular event; TLR target
lesion revascularization; QWMI Q-wave myocardial infarction; NQWMI non Q-wave myocar-
dial infarction; ST stent thrombosis; Maxmaximum.
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Introduction: Percutaneous coronary intervention (PCI) of heavily calcified
lesions is a challenge for the interventional cardiologist. The aim of this study was
to investigate the immediate and long-term outcome of patients (pts) treated with
rotational atherectomy (RA).
Methods: All consecutive pts treated by PCI with RA at our center between 09/1998-
12/2011 entered in a database and were analyzed retrospectively. Clinical indication were
Acute Coronary Syndrome in 148 pts (52%). Data of early and late (mean follow-up
6952 months) major adverse cardiac events (MACE) included cardiac death, stroke,
acute myocardial infarction (AMI) and target lesion failure (TLF).
Results: A total of 283 pts (306 lesions) were included. Mean age was 7010, 80% were
male, 33% diabetic and 42% had chronic renal failure (CRF). 234 pts (83%) had
multivessel disease. According to ACC/AHA classification, 79% were type C. Mean
vessel diameter was 3.30.4 mm. After RA, cutting-balloon (CB) was used in 35% of
cases. Drug eluting stents (DES) were implanted in 44% of pts, bare metal (BMS) in 47%.
Pts were divided in two groups, according to Burr/Artery Ratio (BAR): group 1 (BAR
0.5 plus cutting-balloon use, 64%) and group 2 (BAR0.5 with or without cutting-
balloon, 31%). Procedural success was 96.6%, early mortality 1.4%, stroke or TIA 1.4%,
acute renal injury 5.3%. CK-MB rise 5x Upper Limit value occurred in 2.8% of pts and
vessel perforation in 1.4%. CRF (95% CI,1.2-1.7,p0.03), Peripheral Artery Disease (CI
95%1.6-6.6,p0.006), no use of cutting-balloon in lesion treated with BAR  0.5 (CI
95% 1.2-42.3, p0.0001) and transient/persistent slow-no flow (CI 95% 1.5-9.8,
p0.01) were independent predictor of MACEs. Persistent no-slow flow occurred
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